借助产前照护衔接方案提升丙型肝炎治疗可及性:一项医疗系统质量改进研究

Enhanced Hepatitis C Treatment Access Through an Antenatal Linkage-to-Care Bundle: A Health System Quality Improvement

Implementation of the HALT-C antenatal linkage-to-care bundle significantly increased hepatitis C treatment initiation and completion by six months postpartum, with majority of patients preferring antenatal therapy, demonstrating pregnancy as a critical opportunity for intervention.
中国银屑病患者生物制剂治疗前高结核风险临床评分的开发与验证

Development and Validation of a Clinical Score for Predicting High Tuberculosis Risk in Chinese Psoriasis Patients Prior to Biologic Therapy

A multicenter Chinese study developed and externally validated the Psoriasis TB Risk Score (PTRS) to stratify psoriasis patients' risk of high interferon-γ release assay (IGRA) responses before biologic treatment, facilitating tailored TB screening in high-burden settings.
腹部实体器官移植受者脓毒症的独特免疫谱与生存获益:一项多中心前瞻性队列研究

Distinct Immunological Profiles and Improved Survival in Sepsis among Abdominal Solid Organ Transplant Recipients: Insights from a Multicenter Prospective Cohort Study

Abdominal solid organ transplant recipients with sepsis show improved survival linked to distinctive immune and metabolic signatures, including attenuated inflammation and preserved innate immunity, providing novel insights for clinical management.
每8周一次长效注射卡博特韦-利匹韦林用于撒哈拉以南非洲HIV感染青少年:来自LATA试验及当代证据的启示

Long-Acting Injectable Cabotegravir-Rilpivirine Every 8 Weeks for Adolescents with HIV in Sub-Saharan Africa: Evidence from the LATA Trial and Contemporary Context

The LATA trial demonstrates that long-acting injectable cabotegravir-rilpivirine given every 8 weeks is superior to daily oral ART for maintaining virological suppression in adolescents with HIV in sub-Saharan Africa, with a favorable safety and acceptability profile, heralding a transformative option for this vulnerable population.